Table 2.
Description of the quantitative and qualitative characteristics of patients with multiple sclerosis (mean ± SD or n [percentage])
| Characteristics | n (%) or mean ± SD |
|---|---|
| Men/women | 2/9 |
| Age at MS diagnosis, yr | 31.09±7.48 |
| Age at blood sampling (M00), yr | 39.00±7.07 |
| Previous treatment | |
| IFN-β | 7 (64) |
| Glatiramer acetate | 6 (55) |
| Immunosuppressor | 2 (18) |
| Response to natalizumab at 1 yr | 11 (100) |
MS, multiple sclerosis; M00, month 0 (inclusion time).